Skip to main content

FOSFATASAS DE TIROSINAS: NUEVAS DIANAS TERAPEUTICAS ANTITUMORALES

SAF2013-48812-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2013
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre ASOC INSTITUTO DE INVESTIGACION SANITARIA BIOBIZKAIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

The extended family of protein tyrosine phosphatases

  • Alonso, Andrés
  • Nunes-Xavier, Caroline E.
  • Bayón, Yolanda
  • Pulido, Rafael
In higher eukaryotes, the Tyr phosphorylation status of cellular proteins results from the coordinated action of Protein Tyrosine Kinases (PTKs) and Protein Tyrosine Phosphatases (PTPs). PTPs have emerged as highly regulated enzymes with diverse substrate specificity, and proteins with Tyr-dephosphorylation or Tyr-dephosphorylation-like properties can be clustered as the PTPome. This includes proteins from the PTP superfamily, which display a Cys-based catalytic mechanism, as well as enzymes from other gene families (Asp-based phosphatases, His-based phosphatases) that have converged in protein Tyr-dephosphorylation-related functions by using non-Cys-based catalytic mechanisms. Within the Cys-based members of the PTPome, classical PTPs dephosphorylate specific phosphoTyr (pTyr) residues from protein substrates, whereas VH1-like dual-specificity PTPs dephosphorylate pTyr, pSer, and pThr residues, as well as nonproteinaceous substrates, including phosphoinositides and phosphorylated carbohydrates. In addition, several PTPs have impaired catalytic activity as a result of amino acid substitutions at their active sites, but retain regulatory functions related with pTyr signaling. As a result of their relevant biological activity, many PTPs are linked to human disease, including cancer, neurodevelopmental, and metabolic diseases, making these proteins important drug targets and molecular markers in the clinic. Here, a brief overview on the biochemistry and physiology of the different groups of proteins that belong to the mammalian PTPome is presented., The work in RP laboratory is supported in part by grants SAF2013-48812-R from Ministerio de Economía y Competitividad (Spain), 2013111011 from Gobierno Vasco, Departamento de Salud (Basque Country, Spain), and BIO13/CI/001/BC from BIOEF/ EITB maratoia (Basque Country, Spain)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The extended human PTPome: a growing tyrosine phosphatase family

  • Alonso, Andrés
  • Pulido, Rafael
Tyr phosphatases are, by definition, enzymes that dephosphorylate phospho-Tyr (pTyr) from proteins. This activity is found in several structurally diverse protein families, including the protein Tyr phosphatase (PTP), arsenate reductase, rhodanese, haloacid dehalogenase (HAD) and His phosphatase (HP) families. Most of these families include members with substrate specificity for non-pTyr substrates, such as phospho-Ser/phospho-Thr, phosphoinositides, phosphorylated carbohydrates, mRNAs, or inorganic moieties. A Cys is essential for catalysis in PTPs, rhodanese and arsenate reductase enzymes, whereas this work is performed by an Asp in HAD phosphatases and by a His in HPs, via a catalytic mechanism shared by all of the different families. The category that contains most Tyr phosphatases is the PTP family, which, although it received its name from this activity, includes Ser, Thr, inositide, carbohydrate and RNA phosphatases, as well as some inactive pseudophosphatase proteins. Here, we propose an extended collection of human Tyr phosphatases, which we call the extended human PTPome. The addition of new members (SACs, paladin, INPP4s, TMEM55s, SSU72, and acid phosphatases) to the currently categorized PTP group of enzymes means that the extended human PTPome contains up to 125 proteins, of which ~ 40 are selective for pTyr. We set criteria to ascribe proteins to the extended PTPome, and summarize the more important features of the new PTPome members in the context of their phosphatase activity and their relationship with human disease. Dephosphorylation of phospho-Tyr from proteins is exerted by several protein families, including Cys-, Asp-, and His-based PTPs, and several PTPs display substrate specificity towards non-phospho-Tyr substrates, such as phospho-Ser/Thr or phospho-inositides, among others. Here, we define criteria to ascribe proteins to the Tyr phosphatase family (extended PTPome), present an open list of PTPome members, and summarize their more important features and their relation with human disease., The laboratory of R. Pulido is supported in part bygrants SAF2013-48812-R from Ministerio de Economía y Competitividad (Spain), 2013111011 from Gobierno Vasco, Departamento de Salud (BasqueCountry, Spain), and BIO13/CI/001/BC from BIOEF/EITB maratoia (Basque Country, Spain)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A functional dissection of PTEN N-terminus: Implications in PTEN subcellular targeting and tumor suppressor activity

  • Gil, Anabel
  • Rodríguez-Escudero, Isabel
  • Stumpf, Miriam
  • Molina, María
  • Cid, Víctor J.
  • Pulido, Rafael
© 2015 Gil et al., Spatial regulation of the tumor suppressor PTEN is exerted through alternative plasma membrane, cytoplasmic, and nuclear subcellular locations. The N-terminal region of PTEN is important for the control of PTEN subcellular localization and function. It contains both an active nuclear localization signal (NLS) and an overlapping PIP2-binding motif (PBM) involved in plasma membrane targeting. We report a comprehensive mutational and functional analysis of the PTEN N-terminus, including a panel of tumor-related mutations at this region. Nuclear/cytoplasmic partitioning in mammalian cells and PIP3 phosphatase assays in reconstituted S. cerevisiae defined categories of PTEN N-terminal mutations with distinct PIP3 phosphatase and nuclear accumulation properties. Noticeably, most tumor-related mutations that lost PIP3 phosphatase activity also displayed impaired nuclear localization. Cell proliferation and soft-agar colony formation analysis in mammalian cells of mutations with distinctive nuclear accumulation and catalytic activity patterns suggested a contribution of both properties to PTEN tumor suppressor activity. Our functional dissection of the PTEN N-terminus provides the basis for a systematic analysis of tumor-related and experimentally engineered PTEN mutations., This work was supported in part by grants SAF2009-10226 from Ministerio Ciencia e Innovación (Spain and Fondo Europeo de Desarrollo Regional), SAF2013-48812-R from Ministerio de Economía y Competitividad (Spain), BIO2010-22369-C02-01 from Ministerio de Ciencia e Innovación (Spain), and S2011/BMD-2414 from Comunidad Autónoma de Madrid (Spain). A. Gil has been the recipient of CP04/00318 research contract from Instituto de Salud Carlos III (Spain).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

PTEN recruitment controls synaptic and cognitive function in Alzheimer's models

  • Knafo, Shira
  • Sánchez-Puelles, Cristina
  • Palomer, Ernest
  • Delgado, Igotz
  • Draffin, Jonathan E
  • Mingo, Janire
  • Wahle, Tina
  • Kaleka, Kanwardeep
  • Mou, Liping
  • Pereda-Perez, Inmaculada
  • Klosi, Edvin
  • Faber, Erik B
  • Chapman, Heidi M
  • Lozano-Montes, Laura
  • Ortega-Molina, Ana
  • Ordóñez-Gutiérrez, Lara
  • Wandosell, Francisco
  • Viña, Jose
  • Dotti, Carlos G
  • Hall, Randy A
  • Pulido, Rafael
  • Gerges, Nashaat Z
  • Chan, Andrew M
  • Spaller, Mark R
  • Serrano, Manuel
  • Venero, César
  • Esteban, José A.
Dyshomeostasis of amyloid-β peptide (Aβ) is responsible for synaptic malfunctions leading to cognitive deficits ranging from mild impairment to full-blown dementia in Alzheimer's disease. Aβ appears to skew synaptic plasticity events toward depression. We found that inhibition of PTEN, a lipid phosphatase that is essential to long-term depression, rescued normal synaptic function and cognition in cellular and animal models of Alzheimer's disease. Conversely, transgenic mice that overexpressed PTEN displayed synaptic depression that mimicked and occluded Aβ-induced depression. Mechanistically, Aβ triggers a PDZ-dependent recruitment of PTEN into the postsynaptic compartment. Using a PTEN knock-in mouse lacking the PDZ motif, and a cell-permeable interfering peptide, we found that this mechanism is crucial for Aβ-induced synaptic toxicity and cognitive dysfunction. Our results provide fundamental information on the molecular mechanisms of Aβ-induced synaptic malfunction and may offer new mechanism-based therapeutic targets to counteract downstream Aβ signaling., This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (CSD-2010-00045, SAF-2011-24730 and SAF2014-57233-R to J.A.E.; SAF2010-15676, SAF2013-43902-R and SAF2015-62540-ERC to S.K.; SAF-2009-09129 to C.V.; SAF2009-12249-C02-01 to F.W.; CSD2010-00045 and SAF2010-14906 to C.G.D.; SAF2013-48812-R to R.P.). The laboratory of S.K. is supported by a grant from Alzheimer's Association (NIRG-13-279533), from the Basque Ministry of Health (2013111138), from the University of the Basque Country (EHUrOPE14/03) and from Ikerbasque foundation. The laboratory of F.W. is also supported by CIBERNED (an initiative of ISCIII) and by EU-FP7-2009-CT222887 grant. M.S. is funded by grants from the MINECO, European Union (ERC Advanced Grant), Regional Government of Madrid, Botín Foundation, Ramón Areces Foundation, and AXA Foundation. A.M.C. is funded by grants R01CA095063 and R21CA133669 from the US National Institutes of Health. T.W. is funded from the Federal Office for Scientific Affairs (IUAP P6/43) and Flemish Government's Methusalem Grant. N.Z.G. is funded from the US National Institute on Aging (AG032320), Alzheimer's Association and American Health Assistance Foundation (AHAF). S.K. was the recipient of a “Ramón y Cajal” contract from the Spanish Ministry of Science and Innovation and is now an IkerBasque Research Professor. C.S.-P. is a recipient of an FPI scholarship from the Spanish Ministry of Economy and Competitiveness (BES-2011-043464). J.M. is the recipient of a predoctoral fellowship (PRE_2014_1_285) from Gobierno Vasco, Departamento de Educación (Basque Country, Spain)., Peer reviewed